Stay updated on Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Sign up to get notified when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.

Latest updates to the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.4.2 and removed the funding-lapse notice as well as the earlier Revision: v3.4.1. No trial data or study details were modified.SummaryDifference0.4%

- Check8 days agoChange DetectedNotice about lapse in government funding added and page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check15 days agoChange DetectedAdded a glossary toggle, updated the label 'Last Update' to 'Last Update Submitted that Met QC Criteria', added a No FEAR Act Data item, and updated the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedPage revision updated to v3.3.4 (from v3.3.3); no study content, eligibility criteria, or location details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedLocations sections were reorganized: a new top-level Locations heading now contains state subsections (Arizona, California, Florida, Georgia, Maryland, Texas), and the separate state-location blocks were removed.SummaryDifference0.7%

- Check79 days agoChange DetectedRevision: v3.3.2 has replaced v3.2.0 on the page; this is a minor update that does not alter study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.